Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 472-476

  Beretta, Alberto ^a   Weiss, Stanley H ^b   Rappocciolo, Giovanna ^b   Mayur, Raghavan ^b   De Santis, Claudio ^b   Quirinale, John ^b   Cosma, Antonio ^b   Robbioni, Fiera ^b   Shearer, Gene M ^b   Berzofsky, J A ^b   Villa, Maria Luisa ^b   Siccardi, Antonio G ^b   Clerici, Mario ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; PRIORITY JOURNAL; RISK ASSESSMENT; T LYMPHOCYTE ACTIVATION;

EID: 19144366615     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.472     Document Type: Article

References (14)

1. Fauci AS. Multifactorial nature of HIV disease: implication for therapy. Science 1993;262:1011-8.
2. Clerici M, Shearer CM. The Th1/Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
3. h2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-11.
4. Clerici M, Clark EA, Polacino P, et al. T cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 1994;8:1391-5.
5. Stott EJ. Anti-cell antibodies in macaques. Nature 1991;353:393-4.
6. MAc-32H. AIDS 1995;9:223-8.
7. Lopalco L, De Santis C, Meneveri R, et al. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I α-1 peptide binding domain. Eur J Immunol 1993;23:2016-21.
8. De Santis C, Lopalco L, Robbioni P, et al. Human antibodies to immunodominam C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells. AIDS Res Hum Retroviruses 1993;10:157-62.
9. De Santis C, Robbioni P, Longhi R, et al. Cross-reactive response to human immunodeficiency virus type I (HIV-1) gp120 and HLA class I heavy chains induced by receipt of HIV-1 -derived envelope vaccines. J Infect Dis 1993;168:1396-403.
10. Corbeau P, Olive D, Devaux C. Anti-HLA antigen class I heavy chain monoclonal antibodies inhibit human immunodeficiency virus production by peripheral blood mononuclear cells. Eur J Immunol 1991;21:865-71.
11. Clerici M, Stocks NI, Zazajac RA, et al. IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic HIV seropositive individuals. Nature 1989;339:383-5.
12. Parham P, Barnstable CJ, Bodmer WF. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens. J Immunol 1979;123:342-9.
13. Beretta A, De Santis C, Cosma A, et al. Anti-HLA antibodies associated with resistance to HIV infection. In: Girard M, Dodet B, eds. Retroviruses of human AIDS and related animal diseases. 9th Colloque des Cent Gardes (Marne la Coquette). Paris: Fondation Mérieux, 1995:63-9.
14. Schulz T, Jameson BA, Lopalco L, Siccardi AG, Weiss RA, Moore JP. Conserved structural features in the interaction between retroviral surface and transmembrane glycoprotein? AIDS Res Hum Retroviruses. 1992;8:1571-80.